October 30, 2024 October 30, 2024Categories News StoriesECOG-ACRIN and Caris partner to learn more from the TAILORx trial
October 30, 2024 October 30, 2024Categories News StoriesUsing the geriatric assessment to actualize goal-concordant care (with EA2186/GIANT study chair Dr. Efrat Dotan)
October 30, 2024 October 30, 2024Categories News StoriesWATCH: Behind the ECOG-ACRIN E1910 trial with lead investigator Dr. Mark Litzow
October 29, 2024 October 29, 2024Categories News StoriesWATCH: Breast Cancer Research Foundation hosts Dr. Joseph Sparano and Amanda Quick of The Pink Agenda to discuss metastatic breast cancer
October 25, 2024 October 25, 2024Categories News StoriesECOG-ACRIN Lymphoma Committee co-chair Andrew Evens comments on the results of the SWOG study S1826, Nivolumab-AVD in Advanced-Stage Classic Hodgkin Lymphoma
October 25, 2024 October 25, 2024Categories News StoriesECOG-ACRIN and Caris to analyze samples from TAILORx (requires free registration)
October 15, 2024 October 15, 2024Categories News StoriesCooperative groups develop consensus nomenclature for radiation targets on future lymphoma clinical trials
October 11, 2024 October 11, 2024Categories News StoriesJournal of Clinical Oncology publishes RTOG 1106/ACRIN 6697 results: Midtreatment PET-adapted radiotherapy dose escalation fails to improve outcomes for lung cancer patients
October 11, 2024 October 11, 2024Categories News StoriesMid-treatment PET-adapted radiotherapy dose escalation fails to improve outcomes for lung cancer patients: Results of NRG-RTOG1106/ECOG-ACRIN 6697
